Muchtar, E., Dispenzieri, A., Sanchorawala, V., Hassan, H., Mwangi, R., Maurer, M., Buadi, F., Lee, H. C., Qazilbash, M., Kin, A., Zonder, J., Arai, S., Chin, M. M., Chakraborty, R., Lentzsch, S., Magen, H., Shkury, E., Sarubbi, C., Landau, H., … Gertz, M. (2025). A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosis. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-025-02535-z

Gui, G., Ravindra, N., Hegde, P. S., Andrew, G., Mukherjee, D., Wong, Z., Auletta, J. J., El Chaer, F., Chen, E. C., Chen, Y.-B., Corner, A., Devine, S. M., Iyer, S. G., Jimenez Jimenez, A. M., De Lima, M. J. G., Litzow, M. R., Kebriaei, P., Saber, W., Spellman, S. R., … Hourigan, C. S. (2024). Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-024-02447-4

Gui, G., Ravindra, N., Hegde, P. S., Andrew, G., Mukherjee, D., Wong, Z., Auletta, J. J., El Chaer, F., Chen, E. C., Chen, Y.-B., Corner, A., Devine, S. M., Iyer, S. G., Jimenez Jimenez, A. M., De Lima, M. J. G., Litzow, M. R., Kebriaei, P., Saber, W., Spellman, S. R., … Hourigan, C. S. (2024). Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-024-02449-2

Mohty, R., Bazarbachi, A. H., Labopin, M., Esteve, J., Kröger, N., Cornelissen, J. J., Blaise, D., Socié, G., Maury, S., Ganser, A., Gedde-Dahl, T., von dem Borne, P., Bourhis, J. H., Bulabois, C. E., Yakoub-Agha, I., Pabst, C., Nguyen, S., Chevallier, P., Huynh, A., … Mohty, M. (2024). Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT. Bone Marrow Transplantation. https://doi.org/10.1038/s41409-024-02384-2

McCarthy, P. L., Attwood, K. M., Liu, X., Chen, G. L., Minderman, H., Alousi, A., Bashey, A., Lowsky, R., Miklos, D. B., Hansen, J., Westervelt, P., Yanik, G., Waller, E. K., Howard, A., Blazar, B. R., Wallace, P. K., Reshef, R., Horowitz, M. M., Maziarz, R. T., … Mohammadpour, H. (2023). Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study. Bone Marrow Transplantation, 59(3), 334–343. https://doi.org/10.1038/s41409-023-02168-0

Pasvolsky, O., Yeshurun, M., Fraser, R., Estrada-Merly, N., Rozovski, U., Shargian-Alon, L., Assal, A., Banerjee, R., Bumma, N., Gale, R. P., Hagen, P., Holmberg, L., Hossain, N. M., Lazarus, H. M., Lee, C., Mian, H., Miller, K. C., Nathan, S., Nagler, A., … D’Souza, A. (2021). Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis. Bone Marrow Transplantation, 57(1), 31–37. https://doi.org/10.1038/s41409-021-01455-y

Jimenez Jimenez, A. M., De Lima, M., Komanduri, K. V., Wang, T. P., Zhang, M.-J., Chen, K., Abdel-Azim, H., Abid, M. B., Aljurf, M., Alkhateeb, H., Assal, A., Bacher, U., Baron, F., Battiwalla, M., Beitinjaneh, A., Bejanyan, N., Bhatt, V. R., Byrne, M., Cahn, J.-Y., … Weisdorf, D. (2021). An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. Bone Marrow Transplantation, 56(12), 3068–3077. https://doi.org/10.1038/s41409-021-01450-3